Hutch News
Results per Page:
Researchers pinpoint 'correlates of protection' for Moderna vaccine
Findings may make it easier to test COVID-19 vaccine updates to protect against variants
'Blobology' no more
Cryo-EM microscopy opens up biology at atomic scales
Fred Hutch mourns sudden loss of Dr. Martin ‘Mac’ Cheever
A long career devoted to bringing immunotherapies from bench to bedside
Ongoing trials test COVID-19 drugs for earlier, easier treatment
Injected monoclonal antibodies or oral antivirals could help more patients recover faster
Matsen, Bedford named Howard Hughes Medical Institute Investigators
Acclaimed computational biologists each awarded 7 years of funding
New concerns about coronavirus evolution in immunosuppressed patients
Experts call for tighter precautions, better treatments, more research
New study finds many cancer patients have no antibodies to measles or mumps
Hospital study shows younger adults, stem cell transplant recipients more likely to have less protection
How RNA-altering drugs might improve anticancer immunotherapies
In lab study, brief disruptions of gene machinery make tumor cells more 'visible' to immune system
Addressing a 'massive unmet need' in COVID-19 treatment
COVID-19 Clinical Research Center tests drugs to reduce severe infections
Hutch researchers discover neutralizing antibodies to parainfluenza
New hope for transplant patients vulnerable to this common respiratory virus
Dr. Mazyar Shadman receives the 2021 Ali Al-Johani Award
Oncologist lauded for his compassion and care for bone marrow transplant patients
Natural protection from COVID-19 gets boost from a single dose of vaccine
Tests of patients' blood show vaccine stirs antibodies against variants and 2003 SARS virus
College students muster for big COVID-19 vaccine study
12,000 participants sought in study to prove if vaccine can block asymptomatic transmission
HIV antibody trial results offer 'proof of concept'
Outcome of AMP shows feasibility of developing potent antibody combinations to block HIV
Community engagement in HIV trials guides equity for COVID-19 vaccine studies
New study highlights longstanding barriers to diversity in prior decade of vaccine trials, despite federal guidelines
Biostatisticians draft blueprints for COVID-19 vax trials
Hutch group applies skills honed during decades of HIV prevention trials to bring about safe and effective vaccines for a new pandemic
What's next for T-cell therapies: Q&A with Dr. Stanley Riddell
After approval of latest cellular therapy for non-Hodgkin lymphoma, the immunologist looks ahead
Building trust in safe and effective COVID-19 vaccines
Convincing millions to get vaccinated will take more than data, facts and figures
Vaccines stop COVID-19 symptoms, but do they stop transmission?
Researchers mull options, including college dorm studies and 'human challenge' trials, to find answer
HIV vaccine trials are complicated by the availability of PrEP
World AIDS Day 2020: Vaccine researchers still find ways to run trials amid growing use of HIV-prevention drugs